Similar Articles
881 Role of cyclooxygenase-2 in gastric cancer development and progression
882 Overexpression of miR-196b and HOXA10 characterize a poor-prognosis gastric cancer subtype
883 Characteristics and prognosis of synchronous multiple early gastric cancer
884 Molecular targeting therapy using bevacizumab for peritoneal metastasis from gastric cancer
885 Diabetes mellitus carries a risk of gastric cancer: A meta-analysis
886 Role of ABCG2 expression driven by cisplatin in platinum-containing chemotherapy for gastric cancer
887 Expression and significance of Musashi-1 in gastric cancer and precancerous lesions
888 Personalizing therapies for gastric cancer: Molecular mechanisms and novel targeted therapies
889 HER2 in gastric cancer: Comparative analysis of three different antibodies using whole-tissue sections and tissue microarrays
890 Interaction between cyclooxygenase-2, Snail, and E-cadherin in gastric cancer cells
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA